{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:51:29Z","timestamp":1791568289969,"version":"4.3.4"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["LX22NPO5104"],"award-info":[{"award-number":["LX22NPO5104"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["LX22NPO5104"],"award-info":[{"award-number":["LX22NPO5104"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"DOI":"10.1007\/s11154-026-10091-0","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:06:09Z","timestamp":1791522369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bone health in diabetes mellitus"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8961-3173","authenticated-orcid":false,"given":"Paula","family":"Hoffmanov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9508-1913","authenticated-orcid":false,"given":"David","family":"Galu\u0161ka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5574-1768","authenticated-orcid":false,"given":"Kate\u0159ina","family":"Ka\u0148kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3471-8702","authenticated-orcid":false,"given":"Monika P\u00e1vkov\u00e1","family":"Goldbergov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"key":"10091_CR1","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.bone.2019.03.039","volume":"123","author":"VN Shah","year":"2019","unstructured":"Shah VN, Joshee P, Sippl R, Pyle L, Vigers T, Carpenter RD, et al. Type 1 diabetes onset at young age is associated with compromised bone quality. Bone. 2019;123:260\u20134. https:\/\/doi.org\/10.1016\/j.bone.2019.03.039.","journal-title":"Bone"},{"key":"10091_CR2","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1515\/jpem.2010.23.7.697","volume":"23","author":"ABR Maggio","year":"2010","unstructured":"Maggio ABR, Ferrari S, Kraenzlin M, Marchand LM, Schwitzgebel V, Beghetti M, et al. Decreased bone turnover in children and adolescents with well controlled type 1 diabetes. J Pediatr Endocrinol Metab. 2010;23:697\u2013707. https:\/\/doi.org\/10.1515\/jpem.2010.23.7.697.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10091_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00592-011-0347-0","volume":"50","author":"R Reyes-Garc\u00eda","year":"2013","unstructured":"Reyes-Garc\u00eda R, Rozas-Moreno P, L\u00f3pez-Gallardo G, Garc\u00eda-Mart\u00edn A, Varsavsky M, Avil\u00e9s-Perez MD, et al. Serum levels of bone resorption markers are decreased in patients with type 2 diabetes. Acta Diabetol. 2013;50:47\u201352. https:\/\/doi.org\/10.1007\/s00592-011-0347-0.","journal-title":"Acta Diabetol"},{"key":"10091_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s11914-022-00740-z","volume":"20","author":"M Tanios","year":"2022","unstructured":"Tanios M, Brickman B, Cage E, Abbas K, Smith C, Atallah M, et al. Diabetes and Impaired Fracture Healing: A Narrative Review of Recent Literature. Curr Osteoporos Rep. 2022;20:229\u201339. https:\/\/doi.org\/10.1007\/s11914-022-00740-z.","journal-title":"Curr Osteoporos Rep"},{"issue":"7\u20138","key":"10091_CR5","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1111\/ans.15878","volume":"90","author":"ZC Ding","year":"2020","unstructured":"Ding ZC, Zeng WN, Rong X, Liang ZM, Zhou ZK. Do patients with diabetes have an increased risk of impaired fracture healing? A systematic review and meta-analysis. ANZ J Surg. 2020;90(7\u20138):1259\u201364. https:\/\/doi.org\/10.1111\/ans.15878.","journal-title":"ANZ J Surg"},{"key":"10091_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11657-026-01667-z","volume":"21","author":"\u00d6\u00d6 G\u00fcl","year":"2026","unstructured":"G\u00fcl \u00d6\u00d6. Bone health and fracture risk in diabetes: A multicenter study. Arch Osteoporos. 2026;21:37. https:\/\/doi.org\/10.1007\/s11657-026-01667-z.","journal-title":"Arch Osteoporos"},{"key":"10091_CR7","doi-asserted-by":"publisher","first-page":"961761","DOI":"10.3389\/fendo.2022.961761","volume":"13","author":"W Chen","year":"2022","unstructured":"Chen W, Mao M, Fang J, Xie Y, Rui Y. Fracture risk assessment in diabetes mellitus. Front Endocrinol. 2022;13:961761. https:\/\/doi.org\/10.3389\/fendo.2022.961761.","journal-title":"Front Endocrinol"},{"key":"10091_CR8","doi-asserted-by":"publisher","first-page":"R127","DOI":"10.1530\/EJE-15-0820","volume":"174","author":"FS Hough","year":"2016","unstructured":"Hough FS, Pierroz DD, Cooper C, Ferrari SL, IOF CSA Bone and Diabetes Working Group. Mechanisms in endocrinology: mechanisms and evaluation of bone fragility in type 1 diabetes mellitus. Eur J Endocrinol. 2016;174:R127-138. https:\/\/doi.org\/10.1530\/EJE-15-0820.","journal-title":"Eur J Endocrinol"},{"key":"10091_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.4239\/wjd.v10.i8.421","volume":"10","author":"S Costantini","year":"2019","unstructured":"Costantini S, Conte C. Bone health in diabetes and prediabetes. World J Diabetes. 2019;10:421\u201345. https:\/\/doi.org\/10.4239\/wjd.v10.i8.421.","journal-title":"World J Diabetes"},{"key":"10091_CR10","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fendo.2013.00072","volume":"4","author":"M Saito","year":"2013","unstructured":"Saito M, Marumo K. Bone quality in diabetes. Front Endocrinol (Lausanne). 2013;4:72. https:\/\/doi.org\/10.3389\/fendo.2013.00072.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"10091_CR11","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.3390\/cells9092073","volume":"9","author":"J-M Kim","year":"2020","unstructured":"Kim J-M, Lin C, Stavre Z, Greenblatt MB, Shim J-H. Osteoblast-Osteoclast Communication and Bone Homeostasis. Cells. 2020;9(9):2073. https:\/\/doi.org\/10.3390\/cells9092073.","journal-title":"Cells"},{"key":"10091_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59101752","volume":"59","author":"D De Leon-Oliva","year":"2023","unstructured":"De Leon-Oliva D, Barrena-Bl\u00e1zquez S, Jim\u00e9nez-\u00c1lvarez L, Fraile-Martinez O, Garc\u00eda-Montero C, L\u00f3pez-Gonz\u00e1lez L, et al. The RANK\u2013RANKL\u2013OPG system: a multifaceted regulator of homeostasis, immunity, and cancer. Medicina (Kaunas). 2023;59:1752. https:\/\/doi.org\/10.3390\/medicina59101752.","journal-title":"Medicina (Kaunas)"},{"key":"10091_CR13","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1359\/jbmr.2002.17.11.1977","volume":"17","author":"K Sj\u00f6gren","year":"2002","unstructured":"Sj\u00f6gren K, Sheng M, Mov\u00e9rare S, Liu J, Wallenius K, T\u00f6rnell J, et al. Effects of liver-derived insulin-like growth factor I on bone metabolism in mice. J Bone Miner Res. 2002;17:1977\u201387. https:\/\/doi.org\/10.1359\/jbmr.2002.17.11.1977.","journal-title":"J Bone Miner Res"},{"key":"10091_CR14","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1172\/JCI15463","volume":"110","author":"S Yakar","year":"2002","unstructured":"Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL, Wu Y, Liu J-L, et al. Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest. 2002;110:771\u201381. https:\/\/doi.org\/10.1172\/JCI15463.","journal-title":"J Clin Invest"},{"key":"10091_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-32931-8","volume":"13","author":"P Gu","year":"2023","unstructured":"Gu P, Pu B, Xin Q, Yue D, Luo L, Tao J, et al. The metabolic score of insulin resistance is positively correlated with bone mineral density in postmenopausal patients with type 2 diabetes mellitus. Sci Rep. 2023;13:8796. https:\/\/doi.org\/10.1038\/s41598-023-32931-8.","journal-title":"Sci Rep"},{"key":"10091_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241512441","volume":"24","author":"SK Wong","year":"2023","unstructured":"Wong SK, Mohamad NV, Jayusman PA, Ibrahim N\u2019I. A review on the crosstalk between insulin and Wnt\/\u03b2-catenin signalling for bone health. Int J Mol Sci. 2023;24:12441. https:\/\/doi.org\/10.3390\/ijms241512441.","journal-title":"Int J Mol Sci"},{"key":"10091_CR17","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.sdentj.2023.05.020","volume":"35","author":"ROM Mohsen","year":"2023","unstructured":"Mohsen ROM, Hassan R. A comparative study of the therapeutic effect of bone marrow mesenchymal stem cells versus insulin on mandibular dento-alveolar complex collagen formation and beta-catenin expression in experimentally induced type I diabetes. Saudi Dent J. 2023;35:668\u201377. https:\/\/doi.org\/10.1016\/j.sdentj.2023.05.020.","journal-title":"Saudi Dent J"},{"key":"10091_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4183\/aeb.2024.27","volume":"20","author":"IC Mogos","year":"2024","unstructured":"Mogos IC, Niculescu DA, Dusceac R, Poiana C, THE INDEPENDENT EFFECTS OF, TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE ON BONE TURNOVER MARKERS. Acta Endocrinol (Buchar). 2024;20:27\u201332. https:\/\/doi.org\/10.4183\/aeb.2024.27.","journal-title":"Acta Endocrinol (Buchar)"},{"key":"10091_CR19","doi-asserted-by":"publisher","first-page":"971960","DOI":"10.3389\/fendo.2022.971960","volume":"13","author":"Y-H Fu","year":"2022","unstructured":"Fu Y-H, Liu W-J, Lee C-L, Wang J-S. Associations of insulin resistance and insulin secretion with bone mineral density and osteoporosis in a general population. Front Endocrinol. 2022;13:971960. https:\/\/doi.org\/10.3389\/fendo.2022.971960.","journal-title":"Front Endocrinol"},{"issue":"5","key":"10091_CR20","doi-asserted-by":"publisher","first-page":"3769","DOI":"10.1002\/jcp.26163","volume":"233","author":"P Tangseefa","year":"2018","unstructured":"Tangseefa P, Martin SK, Fitter S, Baldock PA, Proud CG, Zannettino ACW. Osteocalcin-dependent regulation of glucose metabolism and fertility: skeletal implications for the development of insulin resistance. J Cell Physiol. 2018;233(5):3769\u201383. https:\/\/doi.org\/10.1002\/jcp.26163.","journal-title":"J Cell Physiol"},{"key":"10091_CR21","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.cell.2010.06.003","volume":"142","author":"M Ferron","year":"2010","unstructured":"Ferron M, Wei J, Yoshizawa T, Fattore AD, DePinho RA, Teti A, et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell. 2010;142:296\u2013308. https:\/\/doi.org\/10.1016\/j.cell.2010.06.003.","journal-title":"Cell"},{"key":"10091_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/s8756-3282(98)00095-7","volume":"23","author":"DM Thomas","year":"1998","unstructured":"Thomas DM, Udagawa N, Hards DK, Quinn JM, Moseley JM, Findlay DM, et al. Insulin receptor expression in primary and cultured osteoclast-like cells. Bone. 1998;23:181\u20136. https:\/\/doi.org\/10.1016\/s8756-3282(98)00095-7.","journal-title":"Bone"},{"issue":"1","key":"10091_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1083\/jcb.200204046","volume":"159","author":"T Akune","year":"2002","unstructured":"Akune T, Ogata N, Hoshi K, Kubota N, Terauchi Y, Tobe K, et al. Insulin receptor substrate-2 maintains predominance of anabolic function over catabolic function of osteoblasts. J Cell Biol. 2002;159(1):147\u201356. https:\/\/doi.org\/10.1083\/jcb.200204046.","journal-title":"J Cell Biol"},{"issue":"7","key":"10091_CR24","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1172\/JCI9017","volume":"105","author":"N Ogata","year":"2000","unstructured":"Ogata N, Chikazu D, Kubota N, Terauchi Y, Tobe K, Azuma Y, et al. Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover. J Clin Invest. 2000;105(7):935\u201343. https:\/\/doi.org\/10.1172\/JCI9017.","journal-title":"J Clin Invest"},{"key":"10091_CR25","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/BF02980074","volume":"27","author":"YH Lee","year":"2004","unstructured":"Lee YH, White MF. Insulin receptor substrate proteins and diabetes. Arch Pharm Res. 2004;27:361\u201370. https:\/\/doi.org\/10.1007\/BF02980074.","journal-title":"Arch Pharm Res"},{"key":"10091_CR26","doi-asserted-by":"publisher","first-page":"30998","DOI":"10.1074\/jbc.M204527200","volume":"277","author":"CN Bennett","year":"2002","unstructured":"Bennett CN, Ross SE, Longo KA, Bajnok L, Hemati N, Johnson KW, et al. Regulation of Wnt signaling during adipogenesis. J Biol Chem. 2002;277:30998\u20131004. https:\/\/doi.org\/10.1074\/jbc.M204527200.","journal-title":"J Biol Chem"},{"key":"10091_CR27","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrendo.2010.155","volume":"6","author":"M Kawai","year":"2010","unstructured":"Kawai M, Rosen CJ. PPAR\u03b3: a circadian transcription factor in adipogenesis and osteogenesis. Nat Rev Endocrinol. 2010;6:629\u201336. https:\/\/doi.org\/10.1038\/nrendo.2010.155.","journal-title":"Nat Rev Endocrinol"},{"key":"10091_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/690783","author":"N Napoli","year":"2014","unstructured":"Napoli N, Strollo R, Paladini A, Briganti SI, Pozzilli P, Epstein S. The alliance of mesenchymal stem cells, bone, and diabetes. Int J Endocrinol. 2014. https:\/\/doi.org\/10.1155\/2014\/690783.","journal-title":"Int J Endocrinol"},{"key":"10091_CR29","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/joim.12368","volume":"277","author":"UH Lerner","year":"2015","unstructured":"Lerner UH, Ohlsson C. The WNT system: background and its role in bone. J Intern Med. 2015;277:630\u201349. https:\/\/doi.org\/10.1111\/joim.12368.","journal-title":"J Intern Med"},{"issue":"22","key":"10091_CR30","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.3390\/ijms20225525","volume":"20","author":"K Maeda","year":"2019","unstructured":"Maeda K, Kobayashi Y, Koide M, Uehara S, Okamoto M, Ishihara A, et al. The Regulation of Bone Metabolism and Disorders by Wnt Signaling. Int J Mol Sci. 2019;20(22):5525. https:\/\/doi.org\/10.3390\/ijms20225525.","journal-title":"Int J Mol Sci"},{"key":"10091_CR31","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1101\/gad.8.10.1224","volume":"8","author":"P Tontonoz","year":"1994","unstructured":"Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 1994;8:1224\u201334. https:\/\/doi.org\/10.1101\/gad.8.10.1224.","journal-title":"Genes Dev"},{"key":"10091_CR32","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/jcb.21994","volume":"106","author":"KR Shockley","year":"2009","unstructured":"Shockley KR, Lazarenko OP, Czernik PJ, Rosen CJ, Churchill GA, Lecka-Czernik B, PPAR\u03b32, nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cells. J Cell Biochem. 2009;106:232\u201346. https:\/\/doi.org\/10.1002\/jcb.21994.","journal-title":"J Cell Biochem"},{"key":"10091_CR33","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1007\/s00018-012-1211-2","volume":"70","author":"H Sadie-Van Gijsen","year":"2013","unstructured":"Sadie-Van Gijsen H, Crowther NJ, Hough FS, Ferris WF. The interrelationship between bone and fat: from cellular see-saw to endocrine reciprocity. Cell Mol Life Sci. 2013;70:2331\u201349. https:\/\/doi.org\/10.1007\/s00018-012-1211-2.","journal-title":"Cell Mol Life Sci"},{"key":"10091_CR34","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.tem.2022.03.003","volume":"33","author":"G Pach\u00f3n-Pe\u00f1a","year":"2022","unstructured":"Pach\u00f3n-Pe\u00f1a G, Bredella MA. Bone marrow adipose tissue in metabolic health. Trends Endocrinol Metabolism. 2022;33:401\u20138. https:\/\/doi.org\/10.1016\/j.tem.2022.03.003.","journal-title":"Trends Endocrinol Metabolism"},{"key":"10091_CR35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S2213-8587(14)70007-5","volume":"3","author":"M Devlin","year":"2015","unstructured":"Devlin M, Rosen CJ. The bone fat interface: basic and clinical implications of marrow adiposity. Lancet Diabetes Endocrinol. 2015;3:141\u20137. https:\/\/doi.org\/10.1016\/S2213-8587(14)70007-5.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10091_CR36","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1210\/jc.2015-2338","volume":"100","author":"J Paccou","year":"2015","unstructured":"Paccou J, Hardouin P, Cotten A, Penel G, Cortet B. The Role of Bone Marrow Fat in Skeletal Health: Usefulness and Perspectives for Clinicians. J Clin Endocrinol Metab. 2015;100:3613\u201321. https:\/\/doi.org\/10.1210\/jc.2015-2338.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10091_CR37","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.cmet.2014.06.003","volume":"20","author":"WP Cawthorn","year":"2014","unstructured":"Cawthorn WP, Scheller EL, Learman BS, Parlee SD, Simon BR, Mori H, et al. Bone marrow adipose tissue is an endocrine organ that contributes to increased circulating adiponectin during caloric restriction. Cell Metab. 2014;20(2):368\u201375. https:\/\/doi.org\/10.1016\/j.cmet.2014.06.003.","journal-title":"Cell Metab"},{"key":"10091_CR38","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s11914-016-0336-x","volume":"14","author":"TY Kim","year":"2016","unstructured":"Kim TY, Schafer AL. Diabetes and bone marrow adiposity. Curr Osteoporos Rep. 2016;14:337\u201344. https:\/\/doi.org\/10.1007\/s11914-016-0336-x.","journal-title":"Curr Osteoporos Rep"},{"key":"10091_CR39","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.2147\/CIA.S466446","volume":"19","author":"H Niu","year":"2024","unstructured":"Niu H, Zhou M, Xu X, Xu X. Bone Marrow Adipose Tissue as a Critical Regulator of Postmenopausal Osteoporosis - A Concise Review. Clin Interv Aging. 2024;19:1259\u201372. https:\/\/doi.org\/10.2147\/CIA.S466446.","journal-title":"Clin Interv Aging"},{"issue":"9","key":"10091_CR40","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3390\/cells13090724","volume":"13","author":"E Marinelli Busilacchi","year":"2024","unstructured":"Marinelli Busilacchi E, Morsia E, Poloni A. Bone Marrow Adipose Tissue. Cells. 2024;13(9):724. https:\/\/doi.org\/10.3390\/cells13090724.","journal-title":"Cells"},{"key":"10091_CR41","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1146\/annurev-physiol-021119-034513","volume":"82","author":"FJA de Paula","year":"2020","unstructured":"de Paula FJA, Rosen CJ. Marrow Adipocytes: Origin, Structure, and Function. Annu Rev Physiol. 2020;82:461\u201384. https:\/\/doi.org\/10.1146\/annurev-physiol-021119-034513.","journal-title":"Annu Rev Physiol"},{"key":"10091_CR42","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1096\/fj.201800948RR","volume":"33","author":"DE Maridas","year":"2019","unstructured":"Maridas DE, Rendina-Ruedy E, Helderman RC, DeMambro VE, Brooks D, Guntur AR, et al. Progenitor recruitment and adipogenic lipolysis contribute to the anabolic actions of parathyroid hormone on the skeleton. FASEB J. 2019;33:2885\u201398. https:\/\/doi.org\/10.1096\/fj.201800948RR.","journal-title":"FASEB J"},{"key":"10091_CR43","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3389\/fendo.2016.00127","volume":"7","author":"M Tencerova","year":"2016","unstructured":"Tencerova M, Kassem M. The Bone Marrow-Derived Stromal Cells: Commitment and Regulation of Adipogenesis. Front Endocrinol (Lausanne). 2016;7:127. https:\/\/doi.org\/10.3389\/fendo.2016.00127.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10091_CR44","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/21623945.2016.1149269","volume":"5","author":"EL Scheller","year":"2016","unstructured":"Scheller EL, Burr AA, MacDougald OA, Cawthorn WP. Inside out: bone marrow adipose tissue as a source of circulating adiponectin. Adipocyte. 2016;5:251\u201369. https:\/\/doi.org\/10.1080\/21623945.2016.1149269.","journal-title":"Adipocyte"},{"key":"10091_CR45","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/nyas.12327","volume":"1311","author":"EL Scheller","year":"2014","unstructured":"Scheller EL, Rosen CJ. What\u2019s the matter with MAT? Marrow adipose tissue, metabolism, and skeletal health. Ann N Y Acad Sci. 2014;1311:14\u201330. https:\/\/doi.org\/10.1111\/nyas.12327.","journal-title":"Ann N Y Acad Sci"},{"key":"10091_CR46","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1210\/clinem\/dgaa216","volume":"105","author":"TT Pham","year":"2020","unstructured":"Pham TT, Ivaska KK, Hannukainen JC, Virtanen KA, Lidell ME, Enerb\u00e4ck S, et al. Human Bone Marrow Adipose Tissue is a Metabolically Active and Insulin-Sensitive Distinct Fat Depot. J Clin Endocrinol Metab. 2020;105:2300\u201310. https:\/\/doi.org\/10.1210\/clinem\/dgaa216.","journal-title":"J Clin Endocrinol Metab"},{"key":"10091_CR47","doi-asserted-by":"publisher","first-page":"5187940","DOI":"10.1155\/2018\/5187940","volume":"2018","author":"NA Abdella","year":"2018","unstructured":"Abdella NA, Mojiminiyi OA. Clinical Applications of Adiponectin Measurements in Type 2 Diabetes Mellitus: Screening, Diagnosis, and Marker of Diabetes Control. Dis Markers. 2018;2018:5187940. https:\/\/doi.org\/10.1155\/2018\/5187940.","journal-title":"Dis Markers"},{"key":"10091_CR48","doi-asserted-by":"publisher","first-page":"e060377","DOI":"10.1136\/bmjopen-2021-060377","volume":"13","author":"X Hong","year":"2023","unstructured":"Hong X, Zhang X, You L, Li F, Lian H, Wang J, et al. Association between adiponectin and newly diagnosed type 2 diabetes in population with the clustering of obesity, dyslipidaemia and hypertension: a cross-sectional study. BMJ Open. 2023;13:e060377. https:\/\/doi.org\/10.1136\/bmjopen-2021-060377.","journal-title":"BMJ Open"},{"key":"10091_CR49","doi-asserted-by":"publisher","first-page":"E642","DOI":"10.1210\/jc.2011-2542","volume":"97","author":"RI Pereira","year":"2012","unstructured":"Pereira RI, Snell-Bergeon JK, Erickson C, Schauer IE, Bergman BC, Rewers M, et al. Adiponectin Dysregulation and Insulin Resistance in Type 1 Diabetes. J Clin Endocrinol Metab. 2012;97:E642\u20137. https:\/\/doi.org\/10.1210\/jc.2011-2542.","journal-title":"J Clin Endocrinol Metab"},{"key":"10091_CR50","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.cca.2012.12.007","volume":"417","author":"A Yadav","year":"2013","unstructured":"Yadav A, Kataria MA, Saini V, Yadav A. Role of leptin and adiponectin in insulin resistance. Clin Chim Acta. 2013;417:80\u20134. https:\/\/doi.org\/10.1016\/j.cca.2012.12.007.","journal-title":"Clin Chim Acta"},{"issue":"4","key":"10091_CR51","doi-asserted-by":"publisher","first-page":"e57667","DOI":"10.7759\/cureus.57667","volume":"16","author":"K Manglani","year":"2024","unstructured":"Manglani K, Anika NN, Patel D, Jhaveri S, Avanthika C, Sudan S, et al. Correlation of Leptin in Patients With Type 2 Diabetes Mellitus. Cureus. 2024;16(4):e57667. https:\/\/doi.org\/10.7759\/cureus.57667.","journal-title":"Cureus"},{"key":"10091_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20194873","volume":"20","author":"CE Murray","year":"2019","unstructured":"Murray CE, Coleman CM. Impact of diabetes mellitus on bone health. Int J Mol Sci. 2019;20:4873. https:\/\/doi.org\/10.3390\/ijms20194873.","journal-title":"Int J Mol Sci"},{"key":"10091_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4614-5441-0_1","volume-title":"Diabetes: An Old Disease, a New Insight","author":"K Kaul","year":"2013","unstructured":"Kaul K, Tarr JM, Ahmad SI, Kohner EM, Chibber R. Introduction to Diabetes Mellitus. In: Ahmad SI, editor. Diabetes: An Old Disease, a New Insight. New York, NY: Springer; 2013. p. 1\u201311. https:\/\/doi.org\/10.1007\/978-1-4614-5441-0_1."},{"issue":"1","key":"10091_CR54","doi-asserted-by":"publisher","first-page":"102","DOI":"10.33590\/emjnephrol\/22-00060","volume":"10","author":"M Qaz","year":"2022","unstructured":"Qaz M, Sawaf H, Ismail J, Qazi H, Vachharajani T. Pathophysiology of Diabetic Kidney Disease. EMJ Nephrol. 2022;10(1):102\u201313. https:\/\/doi.org\/10.33590\/emjnephrol\/22-00060.","journal-title":"EMJ Nephrol"},{"key":"10091_CR55","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.1002\/jcb.26097","volume":"118","author":"K Rehman","year":"2017","unstructured":"Rehman K, Akash MSH. Mechanism of generation of oxidative stress and pathophysiology of type 2 diabetes mellitus: how are they interlinked? J Cell Biochem. 2017;118:3577\u201385. https:\/\/doi.org\/10.1002\/jcb.26097.","journal-title":"J Cell Biochem"},{"key":"10091_CR56","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/j.1399-5448.2010.00739.x","volume":"12","author":"EA Hamed","year":"2011","unstructured":"Hamed EA, Faddan NHA, Elhafeez HAA, Sayed D. Parathormone\u201325(OH)-vitamin D axis and bone status in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes. 2011;12:536\u201346. https:\/\/doi.org\/10.1111\/j.1399-5448.2010.00739.x.","journal-title":"Pediatr Diabetes"},{"key":"10091_CR57","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1002\/jcp.22844","volume":"227","author":"KJ Motyl","year":"2012","unstructured":"Motyl KJ, McCauley LK, McCabe LR. Amelioration of Type I Diabetes-induced Osteoporosis by Parathyroid Hormone is Associated with Improved Osteoblast Survival. J Cell Physiol. 2012;227:1326\u201334. https:\/\/doi.org\/10.1002\/jcp.22844.","journal-title":"J Cell Physiol"},{"key":"10091_CR58","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/pedi.12861","volume":"20","author":"GB Fuusager","year":"2019","unstructured":"Fuusager GB, Christesen HT, Milandt N, Schou AJ. Glycemic control and bone mineral density in children and adolescents with type 1 diabetes. Pediatr Diabetes. 2019;20:629\u201336. https:\/\/doi.org\/10.1111\/pedi.12861.","journal-title":"Pediatr Diabetes"},{"key":"10091_CR59","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/nrendo.2016.153","volume":"13","author":"N Napoli","year":"2017","unstructured":"Napoli N, Chandran M, Pierroz DD, Abrahamsen B, Schwartz AV, Ferrari SL. Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol. 2017;13:208\u201319. https:\/\/doi.org\/10.1038\/nrendo.2016.153.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10091_CR60","doi-asserted-by":"publisher","first-page":"ziae003","DOI":"10.1093\/jbmrpl\/ziae003","volume":"8","author":"SR Emerzian","year":"2024","unstructured":"Emerzian SR, Johannesdottir F, Yu EW, Bouxsein ML. Use of noninvasive imaging to identify causes of skeletal fragility in adults with diabetes: a review. JBMR Plus. 2024;8(2):ziae003. https:\/\/doi.org\/10.1093\/jbmrpl\/ziae003.","journal-title":"JBMR Plus"},{"issue":"1","key":"10091_CR61","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00198-023-06935-z","volume":"35","author":"S Bhattacharya","year":"2024","unstructured":"Bhattacharya S, Nagendra L, Chandran M, Kapoor N, Patil P, Dutta D, Kalra S. Trabecular bone score in adults with type 1 diabetes: a meta-analysis. Osteoporos Int. 2024;35(1):105\u201315. https:\/\/doi.org\/10.1007\/s00198-023-06935-z.","journal-title":"Osteoporos Int"},{"issue":"10","key":"10091_CR62","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s00198-019-05053-z","volume":"30","author":"LT Ho-Pham","year":"2019","unstructured":"Ho-Pham LT, Nguyen TV. Association between trabecular bone score and type 2 diabetes: a quantitative update of evidence. Osteoporos Int. 2019;30(10):2079\u201385. https:\/\/doi.org\/10.1007\/s00198-019-05053-z.","journal-title":"Osteoporos Int"},{"issue":"9","key":"10091_CR63","doi-asserted-by":"publisher","first-page":"ziae086","DOI":"10.1093\/jbmrpl\/ziae086","volume":"8","author":"V Van Hulten","year":"2024","unstructured":"Van Hulten V, Sarodnik C, Driessen JHM, Viggers R, Rasmussen NH, Geusens PPMM, Schaper N, Schram MT, De Galan BE, Koster A, Bours SPG, Vestergaard P, Stehouwer CDA, van den Bergh JP. Bone microarchitecture and strength assessed by HRpQCT in individuals with type 2 diabetes and prediabetes: the Maastricht study. JBMR Plus. 2024;8(9):ziae086. https:\/\/doi.org\/10.1093\/jbmrpl\/ziae086.","journal-title":"JBMR Plus"},{"issue":"1","key":"10091_CR64","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/jbmr.3240","volume":"33","author":"EJ Samelson","year":"2018","unstructured":"Samelson EJ, Demissie S, Cupples LA, Zhang X, Xu H, Liu CT, Boyd SK, McLean RR, Broe KE, Kiel DP, Bouxsein ML. Diabetes and deficits in cortical bone density, microarchitecture, and bone size: Framingham HR-pQCT Study. J Bone Min Res. 2018;33(1):54\u201362. https:\/\/doi.org\/10.1002\/jbmr.3240.","journal-title":"J Bone Min Res"},{"key":"10091_CR65","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11914-015-0286-8","volume":"13","author":"H Jiao","year":"2015","unstructured":"Jiao H, Xiao E, Graves DT. Diabetes and Its Effect on Bone and Fracture Healing. Curr Osteoporos Rep. 2015;13:327\u201335. https:\/\/doi.org\/10.1007\/s11914-015-0286-8.","journal-title":"Curr Osteoporos Rep"},{"key":"10091_CR66","doi-asserted-by":"publisher","first-page":"1352819","DOI":"10.3389\/fimmu.2024.1352819","volume":"15","author":"CA Capobianco","year":"2024","unstructured":"Capobianco CA, Hankenson KD, Knights AJ. Temporal dynamics of immune-stromal cell interactions in fracture healing. Front Immunol. 2024;15:1352819. https:\/\/doi.org\/10.3389\/fimmu.2024.1352819.","journal-title":"Front Immunol"},{"key":"10091_CR67","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s11914-018-0458-4","volume":"16","author":"BC Bragdon","year":"2018","unstructured":"Bragdon BC, Bahney CS. Origin of Reparative Stem Cells in Fracture Healing. Curr Osteoporos Rep. 2018;16:490\u2013503. https:\/\/doi.org\/10.1007\/s11914-018-0458-4.","journal-title":"Curr Osteoporos Rep"},{"key":"10091_CR68","unstructured":"Patel P, Hashmi MF. Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Updated April 3, 2024. Available from: NCBI Bookshelf."},{"key":"10091_CR69","doi-asserted-by":"publisher","first-page":"e40743","DOI":"10.7759\/cureus.40743","volume":"15","author":"M Barnett","year":"2023","unstructured":"Barnett M. Association Between Primary Hyperparathyroidism and Secondary Diabetes Mellitus: Findings From a Scoping Review. Cureus. 2023;15:e40743. https:\/\/doi.org\/10.7759\/cureus.40743.","journal-title":"Cureus"},{"key":"10091_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1145467","volume":"14","author":"A Chougule","year":"2023","unstructured":"Chougule A, Baroi S, Czernik PJ, Crowe E, Chang MR, Griffin PR, et al. Osteocytes contribute via nuclear receptor PPAR-alpha to maintenance of bone and systemic energy metabolism. Front Endocrinol. 2023;14:1145467. https:\/\/doi.org\/10.3389\/fendo.2023.1145467.","journal-title":"Front Endocrinol"},{"issue":"9","key":"10091_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101694","volume":"5","author":"Q Gao","year":"2024","unstructured":"Gao Q, Jiang Y, Zhou D, et al. Advanced glycation end products mediate biomineralization disorder in diabetic bone disease. Cell Rep Med. 2024;5(9):101694. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101694.","journal-title":"Cell Rep Med"},{"issue":"1","key":"10091_CR72","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.tem.2013.08.002","volume":"25","author":"MB Manigrasso","year":"2014","unstructured":"Manigrasso MB, Juranek J, Ramasamy R, Schmidt AM. Unlocking the biology of RAGE in diabetic microvascular complications. Trends Endocrinol Metab. 2014;25(1):15\u201322. https:\/\/doi.org\/10.1016\/j.tem.2013.08.002.","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"10091_CR73","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.3390\/ijms23031481","volume":"23","author":"H Kitaura","year":"2022","unstructured":"Kitaura H, Marahleh A, Ohori F, Noguchi T, Nara Y, Pramusita A, Kinjo R, Ma J, Kanou K, Mizoguchi I. Role of the Interaction of Tumor Necrosis Factor-\u03b1 and Tumor Necrosis Factor Receptors 1 and 2 in Bone-Related Cells. Int J Mol Sci. 2022;23(3):1481. https:\/\/doi.org\/10.3390\/ijms23031481.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10091_CR74","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s11914-024-00869-z","volume":"22","author":"KH Molitoris","year":"2024","unstructured":"Molitoris KH, Huang M, Baht GS. Osteoimmunology of fracture healing. Curr Osteoporos Rep. 2024;22(3):330\u20139. https:\/\/doi.org\/10.1007\/s11914-024-00869-z.","journal-title":"Curr Osteoporos Rep"},{"key":"10091_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1250309","volume":"14","author":"DK Khajuria","year":"2023","unstructured":"Khajuria DK, Reider I, Kamal F, Norbury CC, Elbarbary RA. Distinct defects in early innate and late adaptive immune responses typify impaired fracture healing in diet-induced obesity. Front Immunol. 2023;14:1250309. https:\/\/doi.org\/10.3389\/fimmu.2023.1250309.","journal-title":"Front Immunol"},{"key":"10091_CR76","doi-asserted-by":"publisher","first-page":"101757","DOI":"10.1016\/j.bonr.2024.101757","volume":"21","author":"F van Brakel","year":"2024","unstructured":"van Brakel F, Zhao Y, van der Eerden BCJ. Fueling recovery: The importance of energy coupling between angiogenesis and osteogenesis during fracture healing. Bone Rep. 2024;21:101757. https:\/\/doi.org\/10.1016\/j.bonr.2024.101757.","journal-title":"Bone Rep"},{"key":"10091_CR77","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1002\/jcb.25814","volume":"118","author":"A Rezabakhsh","year":"2017","unstructured":"Rezabakhsh A, Cheraghi O, Nourazarian A, Hassanpour M, Kazemi M, Ghaderi S, et al. Type 2 diabetes inhibited human mesenchymal stem cells angiogenic response by over-activity of the autophagic pathway. J Cell Biochem. 2017;118:1518\u201330. https:\/\/doi.org\/10.1002\/jcb.25814.","journal-title":"J Cell Biochem"},{"key":"10091_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20153738","volume":"20","author":"FJ Vizoso","year":"2019","unstructured":"Vizoso FJ, Eiro N, Costa L, Esparza P, Landin M, Diaz-Rodriguez P, et al. Mesenchymal stem cells in homeostasis and systemic diseases: hypothesis, evidences, and therapeutic opportunities. Int J Mol Sci. 2019;20:3738. https:\/\/doi.org\/10.3390\/ijms20153738.","journal-title":"Int J Mol Sci"},{"key":"10091_CR79","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.bone.2017.02.014","volume":"99","author":"JC Lim","year":"2017","unstructured":"Lim JC, Ko KI, Mattos M, Fang M, Zhang C, Feinberg D, et al. TNF\u03b1 contributes to diabetes impaired angiogenesis in fracture healing. Bone. 2017;99:26\u201338. https:\/\/doi.org\/10.1016\/j.bone.2017.02.014.","journal-title":"Bone"},{"key":"10091_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115436","volume":"137","author":"DK Khajuria","year":"2020","unstructured":"Khajuria DK, Soliman M, Elfar JC, Lewis GS, Abraham T, Kamal F, et al. Aberrant structure of fibrillar collagen and elevated levels of advanced glycation end products typify delayed fracture healing in the diet-induced obesity mouse model. Bone. 2020;137:115436. https:\/\/doi.org\/10.1016\/j.bone.2020.115436.","journal-title":"Bone"},{"key":"10091_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.116176","volume":"153","author":"Z Chinipardaz","year":"2021","unstructured":"Chinipardaz Z, Liu M, Graves DT, Yang S. Diabetes impairs fracture healing through disruption of cilia formation in osteoblasts. Bone. 2021;153:116176. https:\/\/doi.org\/10.1016\/j.bone.2021.116176.","journal-title":"Bone"},{"key":"10091_CR82","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/S2213-8587(17)30184-5","volume":"5","author":"R Eastell","year":"2017","unstructured":"Eastell R, Szulc P. Use of bone turnover markers in postmenopausal osteoporosis. Lancet Diabetes Endocrinol. 2017;5:908\u201323. https:\/\/doi.org\/10.1016\/S2213-8587(17)30184-5.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10091_CR83","doi-asserted-by":"publisher","first-page":"7513","DOI":"10.3390\/ijms21207513","volume":"21","author":"T Komori","year":"2020","unstructured":"Komori T. Functions of Osteocalcin in Bone, Pancreas, Testis, and Muscle. Int J Mol Sci. 2020;21:7513. https:\/\/doi.org\/10.3390\/ijms21207513.","journal-title":"Int J Mol Sci"},{"key":"10091_CR84","first-page":"1631","volume":"17","author":"PD Sarkar","year":"2013","unstructured":"Sarkar PD, Choudhury AB. Relationships between serum osteocalcin levels versus blood glucose, insulin resistance and markers of systemic inflammation in central Indian type 2 diabetic patients. Eur Rev Med Pharmacol Sci. 2013;17:1631\u20135.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10091_CR85","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s00198-014-2676-7","volume":"25","author":"J Starup-Linde","year":"2014","unstructured":"Starup-Linde J, Eriksen SA, Lykkeboe S, Handberg A, Vestergaard P. Biochemical markers of bone turnover in diabetes patients\u2013a meta-analysis, and a methodological study on the effects of glucose on bone markers. Osteoporos Int. 2014;25:1697\u2013708. https:\/\/doi.org\/10.1007\/s00198-014-2676-7.","journal-title":"Osteoporos Int"},{"issue":"10","key":"10091_CR86","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.71675","volume":"16","author":"R Tiwari","year":"2024","unstructured":"Tiwari R, Singh S, Bajpai M, Verma N, Verma S. Impact of osteocalcin on glycemic regulation and insulin sensitivity in type 2 diabetes mellitus patients. Cureus. 2024;16(10):e71675. https:\/\/doi.org\/10.7759\/cureus.71675.","journal-title":"Cureus"},{"key":"10091_CR87","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2337\/dc09-1237","volume":"33","author":"Y Winhofer","year":"2010","unstructured":"Winhofer Y, Handisurya A, Tura A, Bittighofer C, Klein K, Schneider B, et al. Osteocalcin is related to enhanced insulin secretion in gestational diabetes mellitus. Diabetes Care. 2010;33:139\u201343. https:\/\/doi.org\/10.2337\/dc09-1237.","journal-title":"Diabetes Care"},{"key":"10091_CR88","doi-asserted-by":"publisher","first-page":"4986735","DOI":"10.1155\/2018\/4986735","volume":"2018","author":"RJ Martinez-Portilla","year":"2018","unstructured":"Martinez-Portilla RJ, Villafan-Bernal JR, Lip-Sosa DL, Meler E, Clotet J, Serna-Vela FJ, et al. Osteocalcin Serum Levels in Gestational Diabetes Mellitus and Their Intrinsic and Extrinsic Determinants: Systematic Review and Meta-Analysis. J Diabetes Res. 2018;2018:4986735. https:\/\/doi.org\/10.1155\/2018\/4986735.","journal-title":"J Diabetes Res"},{"key":"10091_CR89","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s40618-014-0220-4","volume":"38","author":"R Saucedo","year":"2015","unstructured":"Saucedo R, Rico G, Vega G, Basurto L, Cordova L, Galvan R, et al. Osteocalcin, under-carboxylated osteocalcin and osteopontin are not associated with gestational diabetes mellitus but are inversely associated with leptin in non-diabetic women. J Endocrinol Invest. 2015;38:519\u201326. https:\/\/doi.org\/10.1007\/s40618-014-0220-4.","journal-title":"J Endocrinol Invest"},{"key":"10091_CR90","doi-asserted-by":"publisher","first-page":"681","DOI":"10.4314\/ejhs.v30i5.6","volume":"30","author":"S Peivandi","year":"2020","unstructured":"Peivandi S, Yaghoubinia K, Kashi Z, Moradi S, Habibi A. Relationship between Serum Osteocalcin Level and Gestational Diabetes Mellitus: A Case-Control Study. Ethiop J Health Sci. 2020;30:681\u20136. https:\/\/doi.org\/10.4314\/ejhs.v30i5.6.","journal-title":"Ethiop J Health Sci"},{"key":"10091_CR91","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s11914-015-0265-0","volume":"13","author":"MR Rubin","year":"2015","unstructured":"Rubin MR. Bone cells and bone turnover in diabetes mellitus. Curr Osteoporos Rep. 2015;13:186\u201391. https:\/\/doi.org\/10.1007\/s11914-015-0265-0.","journal-title":"Curr Osteoporos Rep"},{"key":"10091_CR92","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bone.2015.11.004","volume":"83","author":"J Starup-Linde","year":"2016","unstructured":"Starup-Linde J, Lykkeboe S, Gregersen S, Hauge E-M, Langdahl BL, Handberg A, et al. Differences in biochemical bone markers by diabetes type and the impact of glucose. Bone. 2016;83:149\u201355. https:\/\/doi.org\/10.1016\/j.bone.2015.11.004.","journal-title":"Bone"},{"key":"10091_CR93","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/cen.12364","volume":"80","author":"T Neumann","year":"2014","unstructured":"Neumann T, Hofbauer LC, Rauner M, Lodes S, K\u00e4stner B, Franke S, et al. Clinical and endocrine correlates of circulating sclerostin levels in patients with type 1 diabetes mellitus. Clin Endocrinol (Oxf). 2014;80:649\u201355. https:\/\/doi.org\/10.1111\/cen.12364.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10091_CR94","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1210\/jc.2011-2186","volume":"97","author":"A Garc\u00eda-Mart\u00edn","year":"2012","unstructured":"Garc\u00eda-Mart\u00edn A, Rozas-Moreno P, Reyes-Garc\u00eda R, Morales-Santana S, Garc\u00eda-Fontana B, Garc\u00eda-Salcedo JA, et al. Circulating Levels of Sclerostin Are Increased in Patients with Type 2 Diabetes Mellitus. J Clin Endocrinol Metabolism. 2012;97:234\u201341. https:\/\/doi.org\/10.1210\/jc.2011-2186.","journal-title":"J Clin Endocrinol Metabolism"},{"key":"10091_CR95","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1210\/jc.2012-1901","volume":"97","author":"A Gaudio","year":"2012","unstructured":"Gaudio A, Privitera F, Battaglia K, Torrisi V, Sidoti MH, Pulvirenti I, et al. Sclerostin levels associated with inhibition of the Wnt\/\u03b2-catenin signaling and reduced bone turnover in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2012;97:3744\u201350. https:\/\/doi.org\/10.1210\/jc.2012-1901.","journal-title":"J Clin Endocrinol Metab"},{"key":"10091_CR96","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1210\/jc.2011-2958","volume":"97","author":"L Gennari","year":"2012","unstructured":"Gennari L, Merlotti D, Valenti R, Ceccarelli E, Ruvio M, Pietrini MG, et al. Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes. J Clin Endocrinol Metab. 2012;97:1737\u201344. https:\/\/doi.org\/10.1210\/jc.2011-2958.","journal-title":"J Clin Endocrinol Metab"},{"key":"10091_CR97","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00198-011-1595-0","volume":"23","author":"A Shu","year":"2012","unstructured":"Shu A, Yin MT, Stein E, Cremers S, Dworakowski E, Ives R, et al. Bone structure and turnover in type 2 diabetes mellitus. Osteoporos Int. 2012;23:635\u201341. https:\/\/doi.org\/10.1007\/s00198-011-1595-0.","journal-title":"Osteoporos Int"},{"key":"10091_CR98","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00774-012-0367-z","volume":"30","author":"A Movahed","year":"2012","unstructured":"Movahed A, Larijani B, Nabipour I, Kalantarhormozi M, Asadipooya K, Vahdat K, et al. Reduced serum osteocalcin concentrations are associated with type 2 diabetes mellitus and the metabolic syndrome components in postmenopausal women: the crosstalk between bone and energy metabolism. J Bone Min Metab. 2012;30:683\u201391. https:\/\/doi.org\/10.1007\/s00774-012-0367-z.","journal-title":"J Bone Min Metab"},{"key":"10091_CR99","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.bone.2013.06.029","volume":"56","author":"M-S Ardawi","year":"2013","unstructured":"Ardawi M-S, Akhbar DH, Alshaikh A, Ahmed MM, Qari MH, Rouzi AA, et al. Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes. Bone. 2013;56:355\u201362. https:\/\/doi.org\/10.1016\/j.bone.2013.06.029.","journal-title":"Bone"},{"issue":"12","key":"10091_CR100","doi-asserted-by":"publisher","first-page":"9814","DOI":"10.3390\/ijms24129814","volume":"24","author":"S Wu","year":"2023","unstructured":"Wu S, Ohba S, Matsushita Y. Single-cell RNA-sequencing reveals the skeletal cellular dynamics in bone repair and osteoporosis. Int J Mol Sci. 2023;24(12):9814. https:\/\/doi.org\/10.3390\/ijms24129814.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10091_CR101","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1016\/j.cell.2024.04.013","volume":"187","author":"S Bandyopadhyay","year":"2024","unstructured":"Bandyopadhyay S, Duffy MP, Ahn KJ, Sussman JH, Pang M, Smith D, et al. Mapping the cellular biogeography of human bone marrow niches using single-cell transcriptomics and proteomic imaging. Cell. 2024;187(12):3120-3140.e29. https:\/\/doi.org\/10.1016\/j.cell.2024.04.013.","journal-title":"Cell"},{"issue":"6","key":"10091_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2023.101145","volume":"11","author":"Z Wu","year":"2024","unstructured":"Wu Z, Hou Q, Chi H, Liu J, Mei Y, Chen T, et al. Single-cell RNA sequencing reveals a distinct profile of bone immune microenvironment and decreased osteoclast differentiation in type 2 diabetic mice. Genes Dis. 2024;11(6):101145. https:\/\/doi.org\/10.1016\/j.gendis.2023.101145.","journal-title":"Genes Dis"},{"key":"10091_CR103","doi-asserted-by":"publisher","unstructured":"Mancinelli L, Schoedel KE, Weiss KR, Intini G. Methods to enable spatial transcriptomics of bone tissues. J Vis Exp. 2024;207. https:\/\/doi.org\/10.3791\/66850.","DOI":"10.3791\/66850"},{"issue":"6","key":"10091_CR104","doi-asserted-by":"publisher","DOI":"10.3390\/cells13060522","volume":"13","author":"W Jiang","year":"2024","unstructured":"Jiang W, Caruana DL, Back J, Lee FY. Unique spatial transcriptomic profiling of the murine femoral fracture callus: a preliminary report. Cells. 2024;13(6):522. https:\/\/doi.org\/10.3390\/cells13060522.","journal-title":"Cells"},{"issue":"1","key":"10091_CR105","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11914-025-00949-8","volume":"24","author":"NV Giger","year":"2026","unstructured":"Giger NV, Wehrle E. Advances in spatial transcriptomics in bone. Curr Osteoporos Rep. 2026;24(1):3. https:\/\/doi.org\/10.1007\/s11914-025-00949-8.","journal-title":"Curr Osteoporos Rep"},{"issue":"1","key":"10091_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-024-01518-2","volume":"16","author":"P Khashayar","year":"2024","unstructured":"Khashayar P, Farahani Rad F, Tabatabaei-Malazy O, MohammadHosseinzadeh Golabchi S, Khashayar P, Mohammadi M, et al. Hypoglycemic agents and bone health; an umbrella systematic review of the clinical trials\u2019 meta-analysis studies. Diabetol Metab Syndr. 2024;16(1):310. https:\/\/doi.org\/10.1186\/s13098-024-01518-2.","journal-title":"Diabetol Metab Syndr"},{"key":"10091_CR107","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1359\/jbmr.090732","volume":"25","author":"MS Molinuevo","year":"2010","unstructured":"Molinuevo MS, Schurman L, McCarthy AD, Cortizo AM, Tolosa MJ, Gangoiti MV, et al. Effect of metformin on bone marrow progenitor cell differentiation: in vivo and in vitro studies. J Bone Miner Res. 2010;25:211\u201321. https:\/\/doi.org\/10.1359\/jbmr.090732.","journal-title":"J Bone Miner Res"},{"key":"10091_CR108","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.bbrc.2010.12.099","volume":"404","author":"WG Jang","year":"2011","unstructured":"Jang WG, Kim EJ, Lee K-N, Son H-J, Koh J-T. AMP-activated protein kinase (AMPK) positively regulates osteoblast differentiation via induction of Dlx5-dependent Runx2 expression in MC3T3E1 cells. Biochem Biophys Res Commun. 2011;404:1004\u20139. https:\/\/doi.org\/10.1016\/j.bbrc.2010.12.099.","journal-title":"Biochem Biophys Res Commun"},{"key":"10091_CR109","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00223-016-0203-x","volume":"100","author":"M Chandran","year":"2017","unstructured":"Chandran M. Diabetes drug effects on the skeleton. Calcif Tissue Int. 2017;100:133\u201349. https:\/\/doi.org\/10.1007\/s00223-016-0203-x.","journal-title":"Calcif Tissue Int"},{"key":"10091_CR110","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13098-017-0232-2","volume":"9","author":"AGD Vianna","year":"2017","unstructured":"Vianna AGD, de Lacerda CS, Pechmann LM, Polesel MG, Marino EC, Borba VZC, et al. Vildagliptin has the same safety profile as a sulfonylurea on bone metabolism and bone mineral density in post-menopausal women with type 2 diabetes: a randomized controlled trial. Diabetol Metab Syndr. 2017;9:35. https:\/\/doi.org\/10.1186\/s13098-017-0232-2.","journal-title":"Diabetol Metab Syndr"},{"key":"10091_CR111","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1210\/jc.2009-0572","volume":"95","author":"B Zinman","year":"2010","unstructured":"Zinman B, Haffner SM, Herman WH, Holman RR, Lachin JM, Kravitz BG, et al. Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes. J Clin Endocrinol Metab. 2010;95:134\u201342. https:\/\/doi.org\/10.1210\/jc.2009-0572.","journal-title":"J Clin Endocrinol Metab"},{"key":"10091_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107990","volume":"159","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Cao Y, Tao Y, E M, Tang J, Liu Y, et al. Sulfonylurea and fracture risk in patients with type 2 diabetes mellitus: a meta-analysis. Diabetes Res Clin Pract. 2020;159:107990. https:\/\/doi.org\/10.1016\/j.diabres.2019.107990.","journal-title":"Diabetes Res Clin Pract"},{"key":"10091_CR113","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s12891-023-06493-9","volume":"24","author":"M Bahardoust","year":"2023","unstructured":"Bahardoust M, Yarali M, Donyadideh G. The use of metformin, sulfonylurea compounds and insulin and the risk of hip fractures in diabetic patients: a systematic review and meta-analysis of observational studies. BMC Musculoskelet Disord. 2023;24:367. https:\/\/doi.org\/10.1186\/s12891-023-06493-9.","journal-title":"BMC Musculoskelet Disord"},{"key":"10091_CR114","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/j.1365-2265.2010.03784.x","volume":"73","author":"Z Berberoglu","year":"2010","unstructured":"Berberoglu Z, Yazici AC, Demirag NG. Effects of rosiglitazone on bone mineral density and remodelling parameters in Postmenopausal diabetic women: a 2-year follow-up study. Clin Endocrinol (Oxf). 2010;73:305\u201312. https:\/\/doi.org\/10.1111\/j.1365-2265.2010.03784.x.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10091_CR115","doi-asserted-by":"publisher","first-page":"23517","DOI":"10.1074\/jbc.M111.324814","volume":"287","author":"A Mieczkowska","year":"2012","unstructured":"Mieczkowska A, Basl\u00e9 MF, Chappard D, Mabilleau G. Thiazolidinediones Induce Osteocyte Apoptosis by a G Protein-coupled Receptor 40-dependent Mechanism. J Biol Chem. 2012;287:23517\u201326. https:\/\/doi.org\/10.1074\/jbc.M111.324814.","journal-title":"J Biol Chem"},{"key":"10091_CR116","doi-asserted-by":"publisher","first-page":"904","DOI":"10.3390\/medicina59050904","volume":"59","author":"R-D Chen","year":"2023","unstructured":"Chen R-D, Yang C-W, Zhu Q-R, Li Y, Hu H-F, Wang D-C, et al. Comparison of the Effects of Metformin and Thiazolidinediones on Bone Metabolism: A Systematic Review and Meta-Analysis. Med Multidisciplinary Digit Publishing Inst. 2023;59:904. https:\/\/doi.org\/10.3390\/medicina59050904.","journal-title":"Med Multidisciplinary Digit Publishing Inst"},{"key":"10091_CR117","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s11914-010-0027-y","volume":"8","author":"B Lecka-Czernik","year":"2010","unstructured":"Lecka-Czernik B. Bone loss in diabetes: use of antidiabetic thiazolidinediones and secondary osteoporosis. Curr Osteoporos Rep. 2010;8:178\u201384. https:\/\/doi.org\/10.1007\/s11914-010-0027-y.","journal-title":"Curr Osteoporos Rep"},{"key":"10091_CR118","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/jbmr.2364","volume":"30","author":"T Fukunaga","year":"2015","unstructured":"Fukunaga T, Zou W, Rohatgi N, Colca JR, Teitelbaum SL. An insulin-sensitizing thiazolidinedione, which minimally activates PPAR\u03b3, does not cause bone loss. J Bone Min Res. 2015;30:481\u20138. https:\/\/doi.org\/10.1002\/jbmr.2364.","journal-title":"J Bone Min Res"},{"issue":"1","key":"10091_CR119","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S2213-8587(14)70227-X","volume":"3","author":"SI Taylor","year":"2015","unstructured":"Taylor SI, Blau JE, Rother KI. Possible adverse effects of SGLT2 inhibitors on bone. Lancet Diabetes Endocrinol. 2015;3(1):8\u201310. https:\/\/doi.org\/10.1016\/S2213-8587(14)70227-X.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10091_CR120","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3390\/medicina60030393","volume":"60","author":"A Wikarek","year":"2024","unstructured":"Wikarek A, Grabarczyk M, Klimek K, Janoska-Gawro\u0144ska A, Suchodolska M, Holecki M. Effect of Drugs Used in Pharmacotherapy of Type 2 Diabetes on Bone Density and Risk of Bone Fractures. Med (Kaunas). 2024;60:393. https:\/\/doi.org\/10.3390\/medicina60030393.","journal-title":"Med (Kaunas)"},{"key":"10091_CR121","doi-asserted-by":"publisher","first-page":"110082","DOI":"10.1016\/j.diabres.2022.110082","volume":"192","author":"W-H Tsai","year":"2022","unstructured":"Tsai W-H, Kong S-K, Lin C-L, Cheng K-H, Cheng Y-T, Chien M-N, et al. Risk of fracture caused by anti-diabetic drugs in individuals with type 2 diabetes: a network meta-analysis. Diabetes Res Clin Pract. 2022;192:110082. https:\/\/doi.org\/10.1016\/j.diabres.2022.110082.","journal-title":"Diabetes Res Clin Pract"},{"issue":"8","key":"10091_CR122","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.99123","volume":"3","author":"JE Blau","year":"2018","unstructured":"Blau JE, Bauman V, Conway EM, Piaggi P, Walter MF, Wright EC, et al. Canagliflozin triggers the FGF23\/1,25-dihydroxyvitamin D\/PTH axis in healthy volunteers in a randomized crossover study. JCI Insight. 2018;3(8):e99123. https:\/\/doi.org\/10.1172\/jci.insight.99123.","journal-title":"JCI Insight"},{"key":"10091_CR123","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1210\/jc.2015-1860","volume":"101","author":"JP Bilezikian","year":"2016","unstructured":"Bilezikian JP, Watts NB, Usiskin K, Polidori D, Fung A, Sullivan D, et al. Evaluation of bone mineral density and bone biomarkers in patients with type 2 diabetes treated with canagliflozin. J Clin Endocrinol Metab. 2016;101:44\u201351. https:\/\/doi.org\/10.1210\/jc.2015-1860.","journal-title":"J Clin Endocrinol Metab"},{"key":"10091_CR124","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.2337\/dc11-1926","volume":"35","author":"J Rosenstock","year":"2012","unstructured":"Rosenstock J, Aggarwal N, Polidori D, Zhao Y, Arbit D, Usiskin K, et al. Dose-ranging effects of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, as add-on to metformin in subjects with type 2 diabetes. Diabetes Care. 2012;35:1232\u20138. https:\/\/doi.org\/10.2337\/dc11-1926.","journal-title":"Diabetes Care"},{"key":"10091_CR125","doi-asserted-by":"publisher","first-page":"100115","DOI":"10.1016\/j.ajmo.2025.100115","volume":"14","author":"B Admani","year":"2025","unstructured":"Admani B, Raza F, Siddiqui F. The Impact of Different Antidiabetic Drugs on Fracture Risk in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials With a Focus on SGLT2 Inhibitors. Am J Med Open. 2025;14:100115. https:\/\/doi.org\/10.1016\/j.ajmo.2025.100115.","journal-title":"Am J Med Open"},{"key":"10091_CR126","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1111\/jdi.13481","volume":"12","author":"B Zhao","year":"2021","unstructured":"Zhao B, Shen J, Zhao J, Pan H. Do sodium-glucose cotransporter 2 inhibitors lead to fracture risk? A pharmacovigilance real-world study. J Diabetes Investig. 2021;12:1400\u20137. https:\/\/doi.org\/10.1111\/jdi.13481.","journal-title":"J Diabetes Investig"},{"key":"10091_CR127","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0377-1237(11)60120-2","volume":"68","author":"M Dutta","year":"2012","unstructured":"Dutta M, Pakhetra R, Garg M. Evaluation of bone mineral density in type 2 diabetes mellitus patients before and after treatment. Med J Armed Forces India. 2012;68:48\u201352. https:\/\/doi.org\/10.1016\/S0377-1237(11)60120-2.","journal-title":"Med J Armed Forces India"},{"key":"10091_CR128","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1007\/s00125-005-1786-3","volume":"48","author":"P Vestergaard","year":"2005","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L. Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia. 2005;48:1292\u20139. https:\/\/doi.org\/10.1007\/s00125-005-1786-3.","journal-title":"Diabetologia"},{"key":"10091_CR129","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2337\/dc07-1736","volume":"31","author":"M Monami","year":"2008","unstructured":"Monami M, Cresci B, Colombini A, Pala L, Balzi D, Gori F, et al. Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study. Diabetes Care. 2008;31:199\u2013203. https:\/\/doi.org\/10.2337\/dc07-1736.","journal-title":"Diabetes Care"},{"key":"10091_CR130","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2147\/DMSO.S101370","volume":"9","author":"S Pscherer","year":"2016","unstructured":"Pscherer S, Kostev K, Dippel F, Rathmann W. Fracture risk in patients with type 2 diabetes under different antidiabetic treatment regimens: a retrospective database analysis in primary care. Diabetes Metab Syndr Obes. 2016;9:17\u201323. https:\/\/doi.org\/10.2147\/DMSO.S101370.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10091_CR131","doi-asserted-by":"publisher","first-page":"3361309","DOI":"10.1155\/2021\/3361309","volume":"2021","author":"T Cai","year":"2021","unstructured":"Cai T, Li H, Jiang L, Wang H, Luo M, Su X, et al. Effects of GLP-1 Receptor Agonists on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus: A 52-Week Clinical Study. Biomed Res Int. 2021;2021:3361309. https:\/\/doi.org\/10.1155\/2021\/3361309.","journal-title":"Biomed Res Int"},{"key":"10091_CR132","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/bcp.12777","volume":"81","author":"G Luo","year":"2016","unstructured":"Luo G, Liu H, Lu H. Glucagon-like peptide\u20101(GLP\u20101) receptor agonists: potential to reduce fracture risk in diabetic patients? Br J Clin Pharmacol. 2016;81:78\u201388. https:\/\/doi.org\/10.1111\/bcp.12777.","journal-title":"Br J Clin Pharmacol"},{"key":"10091_CR133","doi-asserted-by":"publisher","first-page":"6578","DOI":"10.3390\/ijms22126578","volume":"22","author":"H Kitaura","year":"2021","unstructured":"Kitaura H, Ogawa S, Ohori F, Noguchi T, Marahleh A, Nara Y, et al. Effects of Incretin-Related Diabetes Drugs on Bone Formation and Bone Resorption. Int J Mol Sci. 2021;22:6578. https:\/\/doi.org\/10.3390\/ijms22126578.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10091_CR134","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3843","volume":"40","author":"HJ Kim","year":"2024","unstructured":"Kim HJ, Choi SA, Gu MS, Ko SY, Kwon JH, Han JY, et al. Effects of glucagon-like peptide-1 receptor agonist on bone mineral density and bone turnover markers: a meta-analysis. Diabetes Metab Res Rev. 2024;40(6):e3843. https:\/\/doi.org\/10.1002\/dmrr.3843.","journal-title":"Diabetes Metab Res Rev"},{"key":"10091_CR135","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00592-025-02468-5","volume":"62","author":"Y Tan","year":"2025","unstructured":"Tan Y, Liu S, Tang Q. Effect of GLP-1 receptor agonists on bone mineral density, bone metabolism markers, and fracture risk in type 2 diabetes: a systematic review and meta-analysis. Acta Diabetol. 2025;62:589\u2013606. https:\/\/doi.org\/10.1007\/s00592-025-02468-5.","journal-title":"Acta Diabetol"},{"issue":"6","key":"10091_CR136","doi-asserted-by":"publisher","first-page":"e2416775","DOI":"10.1001\/jamanetworkopen.2024.16775","volume":"7","author":"SBK Jensen","year":"2024","unstructured":"Jensen SBK, S\u00f8rensen V, Sandsdal RM, Lehmann EW, Lundgren JR, Juhl CR, et al. Bone Health After Exercise Alone, GLP-1 Receptor Agonist Treatment, or Combination Treatment: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2024;7(6):e2416775. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.16775.","journal-title":"JAMA Netw Open"},{"key":"10091_CR137","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3389\/fphar.2017.00487","volume":"8","author":"Y Yang","year":"2017","unstructured":"Yang Y, Zhao C, Liang J, Yu M, Qu X. Effect of Dipeptidyl Peptidase-4 Inhibitors on Bone Metabolism and the Possible Underlying Mechanisms. Front Pharmacol. 2017;8:487. https:\/\/doi.org\/10.3389\/fphar.2017.00487.","journal-title":"Front Pharmacol"},{"key":"10091_CR138","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1007\/s00198-016-3595-6","volume":"27","author":"HJ Choi","year":"2016","unstructured":"Choi HJ, Park C, Lee Y-K, Ha Y-C, Jang S, Shin CS. Risk of fractures and diabetes medications: a nationwide cohort study. Osteoporos Int. 2016;27:2709\u201315. https:\/\/doi.org\/10.1007\/s00198-016-3595-6.","journal-title":"Osteoporos Int"},{"key":"10091_CR139","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1007\/s00198-017-4051-y","volume":"28","author":"S Dombrowski","year":"2017","unstructured":"Dombrowski S, Kostev K, Jacob L. Use of dipeptidyl peptidase-4 inhibitors and risk of bone fracture in patients with type 2 diabetes in Germany\u2014A retrospective analysis of real-world data. Osteoporos Int. 2017;28:2421\u20138. https:\/\/doi.org\/10.1007\/s00198-017-4051-y.","journal-title":"Osteoporos Int"},{"key":"10091_CR140","doi-asserted-by":"publisher","first-page":"1431292","DOI":"10.3389\/fendo.2024.1431292","volume":"15","author":"QK Liu","year":"2024","unstructured":"Liu QK. Mechanisms of action and therapeutic applications of GLP-1 and dual GIP\/GLP-1 receptor agonists. Front Endocrinol (Lausanne). 2024;15:1431292. https:\/\/doi.org\/10.3389\/fendo.2024.1431292.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10091_CR141","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11154-025-09991-4","volume":"27","author":"W Masson","year":"2026","unstructured":"Masson W, Lobo M, Nogueira JP, Barbagelata L, Touzas P, Fr\u00edas JP. Anti-inflammatory effects of tirzepatide: a systematic review and meta-analysis. Rev Endocr Metab Disord. 2026;27(1):5\u201315. https:\/\/doi.org\/10.1007\/s11154-025-09991-4.","journal-title":"Rev Endocr Metab Disord"},{"issue":"7","key":"10091_CR142","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1210\/clinem\/dgag052","volume":"111","author":"Y Liu","year":"2026","unstructured":"Liu Y, Walzer D, Schmitz S, Shukla AP, Ma X, Chirko D, et al. Skeletal effect of semaglutide and tirzepatide in patients with increased risk of fractures. J Clin Endocrinol Metab. 2026;111(7):1959\u201366. https:\/\/doi.org\/10.1210\/clinem\/dgag052.","journal-title":"J Clin Endocrinol Metab"},{"key":"10091_CR143","doi-asserted-by":"publisher","first-page":"112995","DOI":"10.1016\/j.diabres.2025.112995","volume":"230","author":"YH Hsu","year":"2025","unstructured":"Hsu YH, Liang YC, Chan KC, Chou YH, Wu HT, Ou HY. Association of tirzepatide use with risk of osteoporosis compared with other GLP-1 receptor agonists: A retrospective cohort study using the TriNetX database. Diabetes Res Clin Pract. 2025;230:112995. https:\/\/doi.org\/10.1016\/j.diabres.2025.112995.","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"10091_CR144","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1080\/14740338.2025.2586703","volume":"25","author":"K Hoffmann","year":"2026","unstructured":"Hoffmann K, Michalak M, Rizzo M, Maggio V, Paczkowska A. The efficacy and safety of dual GIP\/GLP1 receptor agonists (tirzepatide) in diabetes and obesity: a systematic review and network meta-analysis. Expert Opin Drug Saf. 2026;25(6):1031\u201346. https:\/\/doi.org\/10.1080\/14740338.2025.2586703.","journal-title":"Expert Opin Drug Saf"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-026-10091-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-026-10091-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-026-10091-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:02:41Z","timestamp":1791565361000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-026-10091-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":144,"alternative-id":["10091"],"URL":"https:\/\/doi.org\/10.1007\/s11154-026-10091-0","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"assertion":[{"value":"29 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval, consent to participate, consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}